Influence of EGFR-activating mutations on sensitivity to tyrosine kinase inhibitors in a KRAS mutant non-small cell lung cancer cell line
Yoshinori Tsukumo(National Institute of Health Sciences), Takayoshi Suzuki(Hokkaido University)
Cited by 16
Related Papers
Translation control during prolonged mTORC1 inhibition mediated by 4E-BP3
|Nature Communications|2016|48